19th Sep 2007 07:02
ABCAM Plc19 September 2007 For immediate release 19 September 2007 ABCAM PLC ("Abcam" or "the Company") Offer Talks Terminated Cambridge UK: On 27 July 2007 the Company announced that it was in preliminarydiscussions with a small number of potential offerors regarding a possible offerfor the Company. The Board of Abcam would like to notify the market that thesediscussions have now terminated. Current trading remains strong and the Board is confident of the outlook for2008. Abcam will announce its results for the year ended 30 June 2007 on 1 October2007. For further information please contact: Abcam + 44 (0) 1223 696000 Jonathan Milner, Chief Executive OfficerEddie Powell, Chief Financial Officerwww.abcam.com Numis Securities Ltd + 44 (0) 20 7260 1000Michael MeadeJames Black Piper Jaffray Ltd +44 (0) 20 3142 8700Neil MackisonJames Steel Buchanan Communications + 44 (0) 20 7466 5000Mark Court / Mary-Jane Johnson Notes for editors: About Abcam plc Abcam is a producer and distributor of research-grade antibodies headquarteredin Cambridge, UK, with a US office located in Cambridge, Massachusetts, and aJapan office in Tokyo. Abcam was admitted to AIM in November 2005 and tradesunder the ticker symbol ABC. The Company produces and distributes its own andthird party produced antibodies to academic and commercial users throughout theworld with product information provided and ordering available through theCompany's website, www.abcam.com. The antibodies are sold under the Abcam brandname. The Company's vision is to build the largest online antibody resource inthe world while also ensuring that the antibodies are of high quality andcommercially viable. Abcam now has an online catalogue of approximately 35,000products, most of which are antibodies, from over 200 suppliers supported byup-to-date and detailed technical data sheets, which are created by the Company.The Company currently employs 130 staff in its three operating companies. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
ABC.L